The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients
Open accessAbstract
mutations strongly predispose to leukemia, immunodeficiency, and/or lymphoedema. We describe a series of 79 patients (53 families) diagnosed since 2011, made up of all patients in France and Belgium, with a follow up of 2249 patients/years. Median age at first clinical symptoms was 18.6 years (range, 0-61 years). Severe infectious diseases (mycobacteria, fungus, and human papilloma virus) and hematologic malignancies were the most common first manifestations. The probability of remaining symptom-free was 8% at 40 years old. Among the 53 probands, 24 had missense mutations including 4 recurrent alleles, 21 had nonsense or frameshift mutations, 4 had a whole-gene deletion, 2 had splice defects, and 2 patients had complex mutations. There were significantly more cases of leukemia in patients with missense mutations (n=14 of 34) than in patients with nonsense or frameshift mutations (n=2 of 28). We also identify new features of the disease: acute lymphoblastic leukemia, juvenile myelomonocytic leukemia, fatal progressive multifocal leukoencephalopathy related to the JC virus, and immune/inflammatory diseases. A revised International Prognostic Scoring System (IPSS) score allowed a distinction to be made between a stable disease and hematologic transformation. Chemotherapy is of limited efficacy, and has a high toxicity with severe infectious complications. As the mortality rate is high in our cohort (up to 35% at the age of 40), hematopoietic stem cell transplantation (HSCT) remains the best choice of treatment to avoid severe infectious and/or hematologic complications. The timing of HSCT remains difficult to determine, but the earlier it is performed, the better the outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Cited by
Clonal hematopoiesis and inflammation – the perpetual cycle
Avagyan, S., & Zon, L. I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.12.001 · Cited by 79
Conditionally pathogenic genetic variants of a hematopoietic disease-suppressing enhancer
Soukup, A. A., Matson, D. R., Liu, P., Johnson, K. D., & Bresnick, E. H. (2021) · Science Advances · doi:10.1126/sciadv.abk3521 · Cited by 15
Hirahara, N., Nakamura, H. M., Sasaki, S., Matsushita, A., Ohba, K., Kuroda, G., Sakai, Y., Shinkai, S., Haeno, H., Nishio, T., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227646 · Cited by 9
Metadata
- Authors
- Donadieu, J., Lamant, M., Fieschi, C., de Fontbrune, F. S., Caye, A., Ouachee, M., Beaupain, B., Bustamante, J., Poirel, H. A., Isidor, B., Van Den Neste, E., Neel, A., Nimubona, S., Toutain, F., Barlogis, V., Schleinitz, N., Leblanc, T., Rohrlich, P., Suarez, F., Ranta, D., Chahla, W. A., Bruno, B., Terriou, L., Francois, S., Lioure, B., Ahle, G., Bachelerie, F., Preudhomme, C., Delabesse, E., Cave, H., Bellanné-Chantelot, C., & Pasquet, M.
- Venue
- Haematologica
- Published
- 2018-05-03
- Volume
- 103
- Issue
- 8
- Pages
- 1278-1287
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2800150695
- Cited by
- 183
- References
- 2
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. https://app.cochat.ai/papers/10.3324/haematol.2017.181909
- The paper
- Donadieu, J., Lamant, M., Fieschi, C., de Fontbrune, F. S., Caye, A., Ouachee, M., Beaupain, B., Bustamante, J., Poirel, H. A., Isidor, B., Van Den Neste, E., Neel, A., Nimubona, S., Toutain, F., Barlogis, V., Schleinitz, N., Leblanc, T., Rohrlich, P., Suarez, F., . . . Pasquet, M. (2018). Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica. https://doi.org/10.3324/haematol.2017.181909
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.